Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$23.26
0.763.38%
Last update: Oct 14, 4:02 PM
$22.35
-0.15-0.67%
Stoke Therapeutics Inc (STOK) Stock Price, Quote, News & History
STOKNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.
Other companies in Stoke Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Stoke Therapeutics has a consensus price target of $41.15.
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $23.26 last updated October 14, 2026 at 4:02 PM EDT.
There are no upcoming dividends for Stoke Therapeutics.
Stoke Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Stoke Therapeutics.
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
